SCHEMBL599503

SCHEMBL599503

[2H]C([2H])([2H])S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13779329 0.83
SCHEMBL29635258 0.72
SCHEMBL5640 0.71
SCHEMBL15869348 0.71
SCHEMBL10417889 0.71
Methane SCHEMBL8836373 0.61
Iodide SCHEMBL377678 0.61
SCHEMBL11319151 0.61
SCHEMBL5859282 0.61
Bromide SCHEMBL6568202 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552756-B2 Deuterated aminothiazole compounds as antiviral compounds INNOVATIVE MOLECULES GMBH (DE) 2026-02-17 US disclosed
US-20230391738-A1 DEUTERATED AMINOTHIAZOLE COMPOUNDS AS ANTIVIRAL COMPOUNDS INNOVATIVE MOLECULES GMBH (DE) 2023-12-07 US disclosed
CN-116783171-A Deuterated aminothiazole compounds as antiviral compounds 创新分子股份有限公司 2023-09-19 CN disclosed
EP-4237414-A1 DEUTERATED AMINOTHIAZOLE COMPOUNDS AS ANTIVIRAL COMPOUNDS Innovative Molecules GmbH (DE) 2023-09-06 EP disclosed
US-11680042-B2 Compounds, reagents, and uses thereof METABOLON, INC. (US) 2023-06-20 US disclosed
WO-2022090409-A1 DEUTERATED AMINOTHIAZOLE COMPOUNDS AS ANTIVIRAL COMPOUNDS INNOVATIVE MOLECULES GMBH (DE) 2022-05-05 WO disclosed
US-10717711-B2 Amino quinazolines as kinase inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-07-21 US disclosed
US-20190194145-A1 AMINO QUINAZOLINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-06-27 US disclosed
US-20180258056-A1 AMINO QUINAZOLINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-09-13 US disclosed
US-9994529-B2 Amino quinazolines as kinase inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-06-12 US disclosed
EP-2744501-B1 AMINO QUINAZOLINES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2016-11-30 EP disclosed
US-20160060249-A1 QUINOLYL AMINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-03-03 US disclosed
EP-2603218-B1 QUINOLYL AMINES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2016-03-02 EP disclosed
US-20140256949-A1 QUINOLYL AMINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-09-11 US disclosed
US-20140206688-A1 AMINO QUINAZOLINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-07-24 US disclosed
US-8324229-B2 Alkylthio pyrimidines as CRTH2 antagonists ACTIMIS PHARMACEUTICALS, INC. (US) 2012-12-04 US disclosed
US-20120041024-A1 QUINOLYL AMINES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2012-02-16 US disclosed
US-20110178180-A1 DEUTERIUM-ENRICHED COLCHICINE, THIOCOLCHICINE, AND DERIVATIVES THEREOF; METHODS OF PREPARATION; AND USE THEREOF MPC OLDCO, INC. 2011-07-21 US disclosed
US-20100298361-A1 Alkylthio Pyrimidines As CRTH2 Antagonists GB005, INC. 2010-11-25 US disclosed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed